Article

Viva, Iconix ink deal to make, distribute Rampage brand

Viva International Group and Iconix Brand Group have signed a multi-year licensing agreement for Viva to produce and distribute Iconix Group's Rampage Eyewear brand globally.

Key Points

Somerville, NJ-Viva International Group and Iconix Brand Group have signed a multi-year licensing agreement for Viva to produce and distribute Iconix Group's Rampage Eyewear brand globally.

Rampage Eyewear will consist of approximately 20 styles that feature a variety of handmade acetate and metal styles. Intricate treatments will include floral plaques, subtle logo treatments, and laser-etched detailing.

The new collection of optical styles will be presented at Vision Expo East 2009. An advertising campaign is scheduled for January 2009 to showcase the Rampage Eyewear brand's fashion-forward eyewear styles.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.